Skip to main content
European Commission logo
IP Helpdesk
General publications

Valo Therapeutics: Developing Personalised Immunotherapies for Cancer

Details

Identification
ISBN 978-92-9469-632-8, Catalogue number EA-02-23-177-EN-N
Publication date
19 December 2023
Author
European Innovation Council and SMEs Executive Agency
Publication type
Case study

Description

This case study showcases how the ground-breaking research of Professor Vincenzo Cerullo and his group at the ImmunoViroTherapy Lab at Helsinki University led to the founding of the spin-out company Valo Therapeutics (ValoTx), setting out to make cancer immunotherapy more effective and accessible to patient.

ValoTx

Files

24 JANUARY 2024
ValoTx: Developing Personalised Immunotherapies for Cancer
English
(HTML)
Download